Globe Life Inc.

Globe Life Inc. (GL) Market Cap

Globe Life Inc. has a market capitalization of $12.36B.

Price: $159.18

4.87 (3.16%)

Market Cap: 12.36B

NYSE · time unavailable

CEO: Frank Martin Svoboda

Sector: Financial Services

Industry: Insurance - Life

IPO Date: 1980-10-01

Website: http://www.home.globelifeinsurance.com

Globe Life Inc. (GL) - Company Information

Market Cap: 12.36B|Sector: Financial Services

Company Profile

Globe Life Inc., through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle to middle income households in the United States. The company operates through four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments. It offers whole life, term life, and other life insurance products; Medicare supplement and supplemental health insurance, such as critical illness and accident plans; and single-premium and flexible-premium deferred annuities. The company was formerly known as Torchmark Corporation and changed its name to Globe Life Inc. in August 2019. Globe Life Inc. was incorporated in 1979 and is headquartered in McKinney, Texas.

Analyst Sentiment

80%
Strong Buy

From 11 Active Polls

1Y Forecast: $174.50

▲ +9.6% Potential Upside

Consensus Target Metrics

Low Bound

$157

Median

$178

High Bound

$185

Average

$175

Price & Moving Averages

Loading chart...

🎯 Wall Street Analyst Intelligence Report

1-Year structural target targets, chart projections, and sentiment maps.

Average 1Y Target
$174.50
▲ +9.62% Upside
Low Target
$157.00
-1% Risk
Median Target
$178.00
12% Mid
High Target
$185.00
16% Max
Consensus
Hold
10 / 28 Buys

Consensus Trend Projection

Trailing closures vs. 12-month metrics map.

Analyst Vote Distribution

Aggregate institutional coverage sentiment weights.

📊 Historical Valuation Multiples

Real-time Trailing Twelve Month (TTM) momentum side-by-side with discrete quarterly metrics.

Fiscal QuarterTTMQ1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024
Period EndingTrailing 12MMar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024
Market Cap ($M)12,35910,91311,30811,93510,37610,9969,3629,3077,775
Enterprise Value ($M)14,88313,43613,78914,34712,92713,56611,93611,9339,972
Price to Earnings Ratio (P/E)10.6010.0810.637.6910.2610.809.177.687.52
Price/Earnings-to-Growth Ratio (PEG)4.3114.703.59175.6511.1912.287.294.42
Price to Sales Ratio (P/S)2.037.007.427.897.007.436.386.395.40
Price to Book Ratio (P/B)2.051.791.892.101.912.031.762.011.49
Price to Free Cash Flow Ratio (P/FCF)10.0527.5634.2657.1935.1726.1729.0829.9021.81
Enterprise Value to Sales (EV/Sales)8.629.059.488.739.168.148.206.92
Enterprise Value to EBITDA (EV/EBITDA)9.2536.5036.3627.9537.1338.6434.2929.2228.19
Debt to Equity Ratio1.570.460.440.480.510.520.520.600.44

GL Growth Runway Model

Standard long term linear growth fade

Multi-Stage Discounted Cash Flow Sandbox

Market Price$159.18
Intrinsic Value$270.88
Market Alignment
Undervalued by 70.2%relative to calculated intrinsic value
9.00%
Exp: 4%4%
i

Growth runway slowdown

This value provides a time window for the growth rate to decline beyond Stage 1 toward the terminal rate. Longer windows are most useful for companies with high growth starting conditions or strong competitive advantages. This option stretches out the growth rate slowdown across 5, 10, or 15-year steps. A high-growth starting condition (exceeding a 25% initial growth rate) automatically applies a curve decay to simulate realistic, rapid market saturation.
i

Terminal growth rate

With long-term inflation between 3-5%, revenue must grow by that baseline to maintain flat real-world market share. This value sets the permanent terminal growth rate to factor into the valuation beyond the growth slowdown runway toward maturity.

3-Stage Financial Runway Horizon

🧠 Perpetuity Horizon Engine (Stage 3: Post-2035)

Terminal FCF Base$1.66B
Perpetuity TV Value$31.33B
Discounted TV (PV)$13.23B
TV Weighting %59.9%
⚠️
Financial Model Disclaimer & Risk Disclosure: This interactive scenario simulator is an educational sandbox provided strictly for informational and analytical research purposes. Core historical financial statements and consensus estimates are sourced directly via Financial Modeling Prep (FMP). All downstream outputs are entirely deterministic, hypothetical projections generated by combining automated mathematical formulas (including linear interpolation and Gaussian bell-curve decay models) with user-selected variables and third-party financial data inputs. Users assume all liability for trading decisions executed based on these sandbox calculations.

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

📘 GLOBE LIFE INC (GL) — Investment Overview

🧩 Business Model Overview

Globe Life is a specialized insurer focused on underwriting and administering life and supplemental health insurance products, with a distribution model that emphasizes long-term relationships with policyholders through insurance intermediaries and direct-to-consumer channels. The value chain is straightforward: Globe Life pools premiums, sets reserves using actuarial models, pays claims as risks materialize, and manages expenses and capital to sustain underwriting profitability over the policy life cycle.

The business exhibits “policy-lifecycle stickiness” driven less by formal switching costs and more by underwriting economics and re-underwriting hurdles: replacing an existing life policy typically involves new underwriting and resets of age-based risk pricing, while supplemental coverage often reflects ongoing household need. From an operational standpoint, the insurer’s moat depends on persistency, underwriting discipline, claims integrity, expense management, and reserve accuracy.

💰 Revenue Streams & Monetisation Model

Revenue is generated primarily from premium income, with economics shaped by three structural levers:

  • Underwriting profitability: premiums priced for expected mortality, morbidity, and policy expenses.
  • Investment spread (float economics): investment income earned on statutory reserves and policyholder funds, net of crediting rates and investment expenses. The insurer monetizes time and scale—capital and reserve balances are “held” before paying claims.
  • Persistency and premium durability: retention reduces acquisition costs per enduring policy dollar and helps stabilize earned premium.

Monetisation is largely recurring through premium renewals and policy servicing. Margin drivers are typically most sensitive to (1) claims trends and benefit utilization, (2) expense ratio control, (3) reserve adequacy and actuarial assumptions, and (4) interest rates influencing investment spread.

🧠 Competitive Advantages & Market Positioning

The competitive advantage is primarily a regulatory and actuarial moat combined with distribution scale and cost discipline.

  • Regulatory moat (capital + compliance): Insurance underwriting is capital-intensive under state regulatory regimes (risk-based capital, statutory reserve requirements, licensing). This raises barriers to entry and constrains weaker competitors.
  • Actuarial underwriting and risk management: Consistent profitability requires disciplined pricing, claims management, and reserve setting. Competitors without similar actuarial depth face earnings volatility and potential capital strain.
  • Operating expense control: Efficient acquisition and servicing economics reduce the drag from distribution costs and improve the loss-cost and expense balance.
  • “Low-cost float” analogue: Unlike deposits at a bank, insurance reserves are contractual obligations funded over time. Efficient reserve management and disciplined investment choices can support an attractive spread profile.

Competitive benchmarking: Globe Life’s focus in life and supplemental protection products differs from broader insurers such as Prudential Financial (more diversified life/retirement), MetLife (broad global insurance and annuities), and Aflac (heavy emphasis on supplemental workplace insurance). Versus these rivals, Globe Life tends to concentrate on middle-market protection products and persistence-driven underwriting economics, aiming to achieve durability through underwriting discipline and distribution execution rather than through product breadth.

🚀 Multi-Year Growth Drivers

Over a 5–10 year horizon, growth is supported by structural demand and operational capabilities rather than reliance on one-cycle factors:

  • Underinsured population and coverage penetration: Many households remain without adequate life and supplemental protection, supporting continued market expansion.
  • Demographic tailwinds: Aging trends increase the addressable need for life and supplemental health coverage.
  • Distribution scalability and persistency: Scaling policy acquisition while maintaining persistency improves lifetime value and stabilizes earned premium.
  • Product and underwriting optimization: Refining underwriting guidance, claims processes, and pricing models can improve cohort profitability and reduce earnings volatility.
  • Capital and investment discipline: Effective management of statutory capital and investment allocations supports resilience through different interest-rate and claims environments.

⚠ Risk Factors to Monitor

  • Interest rate and spread risk: Investment yields, reinvestment rates, and reserve discounting can affect the investment spread and risk-adjusted profitability.
  • Claims and mortality/morbidity deviations: Adverse trends or inadequate assumptions can pressure underwriting results and reserve adequacy.
  • Regulatory and reserving changes: Shifts in state insurance regulation, statutory reserve methodologies, or capital requirements can alter reported profitability and capital availability.
  • Persistency and lapse dynamics: Higher-than-expected policy lapses can reduce earned premium durability and weaken acquisition economics.
  • Distribution and operational risks: Agent productivity, compliance, fraud controls, and cyber/security controls can materially impact expense ratios and claims integrity.

📊 Valuation & Market View

Insurance equities are typically valued on a mix of price-to-book, price-to-earnings/operating earnings, and discounted cash flow or embedded value-style frameworks that reflect the expected profitability of the existing policy base plus new business.

Key valuation drivers include:

  • Quality and durability of underwriting margins (loss and expense discipline).
  • Investment spread resilience through rate cycles.
  • Statutory capital strength and consistent capital generation (ability to write business without impairing capital).
  • Earnings volatility (markets typically discount insurers with less predictable underwriting or reserving patterns).

🔍 Investment Takeaway

Globe Life’s long-term investment case rests on a specialized insurance model where profitability is driven by disciplined underwriting, reserve accuracy, expense control, and the economics of managing large policy reserve balances under stringent regulation. The moat is anchored in regulatory capital requirements, actuarial expertise, and distribution scale—factors that are difficult to replicate without deep underwriting and operational capability. For investors, the central question is the consistency of underwriting and spread through cycles while sustaining capital adequacy and persistency.


⚠ AI-generated — informational only. Validate using filings before investing.

📰 Market News & Coverage

15 Stories Available

Real-time institutional reporting and market updates for GL.

prnewswire.com2026-06-05

Did Globe Life Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.

zacks.com2026-06-05

Buy 5 Stocks With High ROE as Markets Swing on War Skirmishes

ROST joins TEL, CVE, GL and SCHW high-ROE cash cows screened for $1B+ cash flow as markets whip on Iran-U.S. skirmishes.

investors.com2026-05-22

Morgan Stanley And Two Insurance Stocks Hit New Highs

Morgan Stanley stock is in a buy zone of a base. A biometric identity name hit a new high after rebounding following a sell signal.

zacks.com2026-05-22

Globe Life (GL) Up 1.7% Since Last Earnings Report: Can It Continue?

Globe Life (GL) reported earnings 30 days ago. What's next for the stock?

zacks.com2026-05-19

5 Stocks to Watch From Prospering Accident & Health Insurance Industry

Accident and Health Insurance stocks like AFL, UNM, GL, TRUP and EIG are set to gain from rising underwriting exposure and accelerated digitalization. However, pricing pressure is a concern given rising medical costs and inflation.

zacks.com2026-05-13

Why Globe Life (GL) is a Top Momentum Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

zacks.com2026-05-11

GL Stock Near 52-Week High: A Signal for Investors to Hold Tight?

Globe Life is set to grow on rising life and health premiums, stronger investment income and disciplined capital deployment.

prnewswire.com2026-04-30

Globe Life Inc. Declares Dividend

MCKINNEY, Texas, April 30, 2026 /PRNewswire/ -- Globe Life Inc. (NYSE: GL) announced that its Board of Directors has declared a quarterly dividend of $0.3300 per share on all of the outstanding common stock of the Company held of record as of close of business of the Company's transfer agent on July 6, 2026. The dividend will be paid on July 31, 2026.

defenseworld.net2026-04-25

Asset Management One Co. Ltd. Sells 10,518 Shares of Globe Life Inc. $GL

Asset Management One Co. Ltd. trimmed its position in Globe Life Inc. (NYSE: GL) by 78.0% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,972 shares of the company's stock after selling 10,518 shares during the quarter. Asset Management

gurufocus.com2026-04-24

Globe Life Inc (GL) Q1 2026 Earnings Call Highlights: Strong Net Operating Income and Strategic AI Initiatives

Net Income: $271 million, or $3.39 per share, compared to $255 million, or $3.01 per share, a year ago.Net Operating Income: $274 million, or $3.43 per share,

zacks.com2026-04-23

Globe Life Q1 Earnings Miss Estimates, Rise Y/Y on Higher Premiums

Globe Life's Q1 earnings miss estimates despite higher premiums and underwriting gains, as rising expenses weigh on results.

seekingalpha.com2026-04-23

Globe Life Inc. (GL) Q1 2026 Earnings Call Transcript

Globe Life Inc. (GL) Q1 2026 Earnings Call Transcript

zacks.com2026-04-22

Globe Life (GL) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

While the top- and bottom-line numbers for Globe Life (GL) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

zacks.com2026-04-22

Globe Life (GL) Q1 Earnings and Revenues Miss Estimates

Globe Life (GL) came out with quarterly earnings of $3.43 per share, missing the Zacks Consensus Estimate of $3.46 per share. This compares to earnings of $3.07 per share a year ago.

prnewswire.com2026-04-22

GLOBE LIFE INC. REPORTS FIRST QUARTER 2026 RESULTS

MCKINNEY, Texas, April 22, 2026 /PRNewswire/ -- Globe Life Inc. (NYSE: GL) reported today that for the quarter ended March 31, 2026, net income was $3.39 per diluted common share, compared with $3.01 per diluted common share for the year-ago quarter. Net operating income was $3.43 per diluted common share, compared with $3.07 per diluted common share for the year-ago quarter.

📊 AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2026-03-31

"GL delivered Q1 2026 revenue of $1.56B and net income of $270.5M (EPS $3.45). On a YoY basis (vs Q1 2025), revenue grew from $1.48B to $1.56B (+5.32%) and net income increased from $254.6M to $270.5M (+6.31%), with net margin essentially flat (17.20% → 17.35%). QoQ (vs Q4 2025), revenue rose modestly (+2.40%; $1.52B → $1.56B) while net income was slightly higher (+1.70%; $266.0M → $270.5M). Profitability improved at the gross and operating levels versus Q4: gross margin expanded materially (30.36% → 49.37%), lifting operating income margin (23.38% → 23.60%) and supporting stable net margin. Cash flow remained solid: operating cash flow was $420.9M and free cash flow $396.0M. Shareholder returns appear favorable: the stock is up +25.28% over the last year, and the dividend yield is low (~0.20%); buybacks are active (repurchased $240.5M in Q1 2026). Balance sheet resilience is strong with total assets at ~$30.97B and equity at ~$6.08B. Leverage is low (net debt ~ $0.20B; debt/equity ~0.08) and liquidity improved (cash & ST investments ~ $439.0M)."

Revenue Growth

Good

QoQ revenue +2.40% ($1.52B to $1.56B). YoY revenue +5.32% ($1.48B to $1.56B), indicating steady demand.

Profitability

Good

YoY net margin held roughly flat (17.20% → 17.35%) while gross margin improved sharply vs Q4 (30.36% → 49.37%). EPS rose from $3.05 (Q1 2025) to $3.45.

Cash Flow Quality

Strong

Operating cash flow $420.9M and free cash flow $396.0M in Q1 2026. Repurchases ($240.5M) continue alongside modest dividends ($21.4M).

Leverage & Balance Sheet

Strong

Low leverage and stable equity: total assets ~$30.97B, equity ~$6.08B. Net debt ~ $0.20B and debt/equity ~0.08 suggest strong resilience.

Shareholder Returns

Strong

1-year price momentum is strong (+25.28%), enhancing total return. Dividend yield is small (~0.20%), but buybacks are meaningful in the quarter.

Analyst Sentiment & Valuation

Neutral

With price at $151.86 vs consensus target ~$171.25, implied upside exists (~13%), but valuation remains mid-range given forward appeal is only moderate.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Fundamentals Overview

Loading fundamentals overview...

Globe Life delivered strong Q1 operating profitability with $3.39 EPS (GAAP net income) and $3.43 net operating EPS, both ahead of prior year, while sustaining underwriting margin stability at 41% life and ~23% health as % of premium. The main earnings swing catalyst is the planned Q3 life assumption-update remeasurement: management estimates a $70M–$110M before-tax benefit, lifting Q3 life margin to 49%–54% while keeping normalized full-year life margin near ~41%. Capital return momentum remains a core equity support: Q1 repurchased ~1.4M shares (~$205M) and the full-year buyback range was increased to $560M–$610M alongside ~$90M dividends. Key operational watch items are elevated 2026 lapse expectations and rebuilding American Income agent count; management points to Q2 middle-management compensation changes and AI-driven expense/productivity improvements as the path to sustained growth.

AI IconGrowth Catalysts

  • Medicare supplement pricing and sales momentum in United American, including tailwinds from Medicare Advantage beneficiaries shifting to Medicare supplement
  • Medicare supplement premium growth supported by approved rate increases expected to contribute about $65 million additional premium in 2026 (primarily last 3 quarters)
  • Direct-to-consumer (DTC) improved lead conversion to agencies driving higher life underwriting margin and supporting incremental advertising/lead investment
  • AI application rollouts aimed at reducing administrative expense growth and improving agent onboarding/training efficiency to raise productivity and retention

Business Development

  • No named external partners/customers/vendors explicitly mentioned in the provided transcript

AI IconFinancial Highlights

  • Net income $271M ($3.39 EPS) vs $255M ($3.01 EPS) YoY; net operating income $274M ($3.43 EPS), +12% vs prior-year $3.07 EPS
  • Premium revenue +6% YoY; full-year total premium revenue expected ~+7%
  • Life premium revenue +3% YoY to $853M; life underwriting margin $349M, +3% YoY; life underwriting margin as % of premium 41% (flat YoY); full-year life margin expected 42%–45%, with ~41% in Q2 and Q4 and higher in Q3 from assumption update remeasurement
  • Health premium revenue +13% YoY to $417M; health underwriting margin +12% to $95M; health underwriting margin as % of premium ~23% (flat YoY); full-year health underwriting margins 23%–27%
  • Administrative expenses $94M (+~8% YoY); admin expenses as % of premium 7.4% vs expectation trending down toward ~7.3% guided for full year; long-term AI expected to lower this ratio further
  • Investment income: excess investment income $37M (+~$1M YoY); net investment income $290M (+3% YoY); earned yield on long-term assets 5.5% (fixed-maturity yield assumptions later clarified below)
  • Investment yield/guidance: fixed-maturity earned yield 2026 expected ~5.3%; total long-term invested assets earned yield 2026 expected 5.45%–5.5%
  • Third-quarter assumption update benefit: estimated before-tax benefit $70M–$110M; guides Q3 life margin as % of premium 49%–54% vs full-year normalized ~41% (excluding the assumption update)
  • Life policy obligations (% of premium) declined to 35.4% from 36.3% YoY (favorable vs management estimates); health policy obligations 56.3% vs 55.6% YoY

AI IconCapital Funding

  • Q1 buyback: ~1.4M shares for ~$205M at average price $141.24
  • Q1 shareholder return: ~$225M including ~$20M dividends
  • Full-year dividend guidance: ~$90M dividend payments reflecting 22% increase in annual dividend rate per share
  • Full-year buyback range increased to $560M–$610M (primary use of excess cash after dividends)
  • Liquidity: parent liquid assets ~$80M at start of year; ~$85M at quarter-end; expects ~$50M–$60M at year-end (target range)
  • Insurance-subsidiary capital target: consolidated company action level RBC ratio 300%–320%; year-end 2025 RBC 316% (~$95M excess above 300% minimum); intends to maintain within 300%–320% for 2026

AI IconStrategy & Ops

  • American Income agency: implemented middle-management compensation adjustments at start of Q2 to emphasize new agent recruiting/retention; expects positive impact on overall agent count in 2H 2026
  • Agent productivity focus: despite Q1 agent count declines at American Income (avg producing agent count 11,064, -4% YoY), management highlighted improved productivity among veteran agents
  • Liberty National: agent count up (avg producing agent count 4,031, +9% YoY) supporting life sales growth (+4% premium YoY; +13% net life sales YoY)
  • Family Heritage: continued recruiting/middle management emphasis with agent count up (1,561, +10% YoY) supporting health net sales (+22% YoY)
  • DTC: expect DTC-generated leads to increase for the 3 exclusive agencies by ~5%–10% during 2026
  • Investment portfolio: ongoing shift to higher-rated value; BBB allocation 41% of fixed maturity (down from 45% YoY), with below-investment-grade 2.7%
  • Investment acquisition planning: at midpoint of guidance assumes ~$800M–$900M fixed-maturity investments at 5.9%–6.1% yield; total ~$1.1B–$1.2B across asset classes at 6.3%–6.5% average yield

AI IconMarket Outlook

  • Full-year 2026 net operating earnings per diluted share guidance: $15.40–$15.90 (about 8% EPS growth at midpoint)
  • Full-year normalized EPS growth (excluding assumption update impacts in 2025 and 2026): ~11% at midpoint
  • Projected 3-year compound annual growth rate of normalized EPS at midpoint: 11.5%
  • Life premium revenue: expected 3%–3.5% full-year; life underwriting margin 42%–45% full-year with Q2/Q4 ~41% and higher Q3 due to assumption updates
  • Health premium growth: 14%–17% full-year; United American expected health margin % of premium 8%–9% with ~10% average underwriting margin % over last 3 quarters as rate increases realized
  • Agent count growth outlook for 2026: American Income low single-digit growth; Liberty National and Family Heritage low double-digit growth
  • Distribution sales outlook for 2026: American Income life mid-single-digit; Liberty National life low double-digit; DTC life low single-digit; Liberty National health mid-single-digit; Family Heritage health low double-digit; United American health high teens growth
  • Bermuda initiative update cadence: expects to file reciprocal jurisdiction in Q2; management indicated no new developments since last call (audits complete on financial statements)

AI IconRisks & Headwinds

  • Lapse rates remain elevated for 2026 vs pre-pandemic; Q1 first-year lapses at American Income were high relative to recent experience but management characterized as a short-term fluctuation rather than a trend break
  • Agent count dynamics: American Income producing agent count down 4% YoY driven by new agent retention decline; long-term growth depends on rebuilding agent count
  • Distribution mix and business composition can influence lapse patterns (worksite business adds higher early-issue-year lapses; DTC internet renewals historically higher; mix shift can lift observed lapse rates)
  • Investment portfolio has $1.6B net underlying loss position due to interest-rate-driven market rates higher than book yield (management not concerned due to intent/ability to hold to maturity)
  • Q4 hurdle risk for United American given very strong prior-year growth (management anticipates sales growth not at the same level in Q4)

Q&A: Analyst Interest

  • Topic: Lapse-rate trends and whether they reflect macro affordability vs distribution-specific mix. Management: expected lapse rates to remain elevated in 2026 versus pre-pandemic due to economic stress and inflation; American Income’s high Q1 first-year lapses deemed a short-term fluctuation; mix effects from worksite and DTC internet business explained parts of the pattern.
  • Topic: Quantifying AI benefits on expenses and productivity. Management: admin-side benefit should show up as moderating administrative expense growth relative to premium growth, targeting margin expansion over time; pilots already running; sales-side AI expected to improve agent onboarding/training efficiency, raise retention, and support higher productivity; embedded in 2026 projections with continued tailwinds into 2027.
  • Topic: Drivers of higher 2026 buyback and revised agent/premium outlook. Management: higher buyback enabled by 2025 statutory earnings finalization and excess cash flows slightly above prior $600M–$700M range; timing accelerated when shares dipped below $140; agent count/premium tempers driven by compensation structure effects and DTC comparable strength in late 2025.

Sentiment: POSITIVE

Note: This summary was synthesized by AI from the GL Q1 2026 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

📋 Official Regulatory 10-K / 10-Q SEC Filings

Direct authenticated documentation links to audited SEC database reports for GL.

SEC EDGAR Live Feed
Loading financial data and tables...
📁

SEC Filings (GL)

© 2026 Stock Market Info — Globe Life Inc. (GL) Financial Profile